Delivery Order SPE2DB22D1202-SPE2DB24FURK2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VEMLIDY 25 MG TABLET medication. The $7,789.59 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,206,161 units of the pharmaceutical product VEMLIDY 25 MG TABLET in 30-count packages. The $5,193.06 delivery order has a performance period through April 9, 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) has awarded a $2,596.53 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564107047 - VEMLIDY 25 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop...
- The Defense Logistics Agency (DLA) has awarded a $5,193.06 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VEMLIDY 25 MG TABLET medical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The $5,193.06 firm fixed-price award does not have a set-aside designation and is scheduled for completion by August 30, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VEMLIDY 25 MG TABLET UU 30S. The order, valued at $7,071.73, has a completion date of January 8, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has provided a range of pharmaceutical products and medical supplies to support DLA's Troop Support Medical programs and facilities....
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VEMLIDY 25 MG TABLET units. The $3,802.02 contract has a completion date of December 20, 2023 and was awarded on December 19, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has an established record of supplying pharmaceuticals, medical equipment, and distribution services to support military...
- The Defense Logistics Agency (DLA) awarded a $2,596.53 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VEMLIDY 25 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The Defense Logistics Agency (DLA) has awarded a $10,445.23 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VEMLIDY 25 MG TABLET UU 30S. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The contract has a ceiling value of $3,835.32 and a period of performance through May 9, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there are no subcontractors mentioned. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FURK2Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VEMLIDY 25 MG TABLET UU 30S. The $4,470.24 contract has a completion date of February 23, 2024. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a $999,999,999.00 potential value and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 2/22/24 |